BioLargo, Inc. announced that it expects to receive $0.815 million in funding
November 16, 2023
Share
BioLargo, Inc. announced that it will receive $815,000 in funding on November 17, 2023. The company will issue common shares in the transaction. The minimum investment accepted from any outside investor is $25,000.
The company will issue securities pursuant to exemption provided under Regulation D.
BioLargo, Inc. is a cleantech and life sciences innovator and engineering services solution provider. The Company invents, develops, and commercializes platform technologies to solve challenging environmental problems like polyfluoroalkyl substances (PFAS) contamination, advanced water and wastewater treatment, industrial odor control, air quality control, infection control, and myriad environmental remediation challenges. The Companyâs segments include ONM Environmental, which manufactures and sells its odor and VOC control products and services, including its flagship product, CupriDyne Clean; BLEST, which provides professional engineering services supporting its internal business units; Clyra Medical, which develops and sells medical products based on its technology; BioLargo Canada, which is primary engaged in research and development activities; and Corporate Operations, which support the operating segments with legal, accounting, human resources, and other services.
BIOLARGO, INC. 
